| 1 |
31604073 | Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells. | 2020 Jan |
4 |
| 2 |
30990221 | TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer. | 2019 Nov 1 |
2 |
| 3 |
31749762 | Non-canonical Estrogen Signaling in Endocrine Resistance. | 2019 |
1 |
| 4 |
28962900 | Effects of tamoxifen on neuronal morphology, connectivity and biochemistry of hypothalamic ventromedial neurons: Impact on the modulators of sexual behavior. | 2018 Jan |
1 |
| 5 |
30153467 | Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes. | 2018 Dec 1 |
1 |
| 6 |
26898104 | Design and synthesis of novel flexible ester-containing analogs of tamoxifen and their evaluation as anticancer agents. | 2016 |
1 |
| 7 |
27486755 | Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ. | 2016 Aug 30 |
2 |
| 8 |
25450264 | The potential role of estrogen receptor β2 in breast cancer. | 2015 Feb |
1 |
| 9 |
25692143 | Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinoma. | 2015 |
2 |
| 10 |
26232188 | The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents. | 2015 Sep |
4 |
| 11 |
26397740 | Autocrine interferon-γ may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor β subtype. | 2015 Dec |
2 |
| 12 |
24184124 | Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells. | 2014 Jan |
1 |
| 13 |
24189439 | Autocrine production of interleukin-6 confers ovarian cancer cells resistance to tamoxifen via ER isoforms and SRC-1. | 2014 Feb 15 |
2 |
| 14 |
24192230 | Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells. | 2014 Apr |
1 |
| 15 |
25084100 | Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer. | 2014 Aug |
1 |
| 16 |
23362266 | Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β. | 2013 Mar 29 |
1 |
| 17 |
23752064 | Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. | 2013 Sep 1 |
5 |
| 18 |
24047421 | Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer. | 2013 Sep 18 |
2 |
| 19 |
24103091 | Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer. | 2013 Dec |
3 |
| 20 |
22642174 | [Estrogen receptors beta--new target in cellular lung cancer treatment]. | 2012 |
1 |
| 21 |
25992213 | Tamoxifen non-estrogen receptor mediated molecular targets. | 2012 Oct 2 |
2 |
| 22 |
21204712 | Estrogen receptor β. | 2011 Jan |
3 |
| 23 |
21233487 | Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sites. | 2011 Apr |
1 |
| 24 |
21492444 | Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity. | 2011 Apr 14 |
4 |
| 25 |
21615662 | The multifaceted role of oestrogen in enhancing Chlamydia trachomatis infection in polarized human endometrial epithelial cells. | 2011 Aug |
1 |
| 26 |
22046795 | [Expression of hormonal receptors (alpha-estrogen, beta-estrogen, progesteron), Ki-67 and P53 in endometrium of tamoxifen treated breast cancer patients]. | 2011 Jul-Sep |
1 |
| 27 |
19434490 | Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. | 2010 Apr |
2 |
| 28 |
19744542 | Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen. | 2010 Feb 5 |
5 |
| 29 |
20005069 | Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects. | 2010 Feb |
1 |
| 30 |
20332105 | The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen. | 2010 Apr 15 |
1 |
| 31 |
20659801 | A mutant selective anti-estrogen is a pure antagonist on EREs and AP-1 response elements. | 2010 Sep 1 |
1 |
| 32 |
20696772 | Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer. | 2010 Sep |
1 |
| 33 |
20827267 | Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results. | 2010 Nov |
2 |
| 34 |
21094378 | Bioanalytical methods for determination of tamoxifen and its phase I metabolites: a review. | 2010 Dec 17 |
1 |
| 35 |
19004482 | Estrogen receptor modulators and estrogen receptor beta immunolabelling in human umbilical vein endothelial cells. | 2009 |
1 |
| 36 |
19059307 | Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements. | 2009 Feb 27 |
1 |
| 37 |
19095770 | Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity. | 2009 Feb |
2 |
| 38 |
19463683 | Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications. | 2009 Aug |
1 |
| 39 |
19528477 | Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells. | 2009 Jun |
2 |
| 40 |
19584281 | Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. | 2009 Jul 15 |
1 |
| 41 |
17638070 | Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. | 2008 May |
5 |
| 42 |
17713466 | Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. | 2008 May |
2 |
| 43 |
17962382 | Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene. | 2008 Feb |
2 |
| 44 |
18026833 | Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas. | 2008 Oct |
2 |
| 45 |
18579664 | Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. | 2008 Jul 15 |
1 |
| 46 |
18663360 | hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen. | 2008 Oct 23 |
1 |
| 47 |
18669459 | Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. | 2008 Aug 1 |
1 |
| 48 |
19000448 | [Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29]. | 2008 Nov |
6 |
| 49 |
19018086 | Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy. | 2008 Dec 20 |
2 |
| 50 |
17404078 | Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. | 2007 Apr 1 |
4 |